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  IMAGE QUALITY OF STANDARD AND SYNTHETIC DIFFUSION 
WEIGHTED MAGNETIC RESONANCE IMAGING IN PROSTATE CANCER 
ADAM TIMOTHY BAKER 
ABSTRACT 
 The extension from Quantitative Magnetic Resonance Imaging to 
synthetic imaging has the clear advantage of being able to continually image the 
patient after the exam. MR techniques such as DWI are commonly used but have 
some clear disadvantages resulting from the use of echoplanar imaging. It should 
then be asked whether one imaging technique is objectively better. If one 
technique is better, the incorporation in clinical settings could produce better 
diagnostic rates, and save valuable time. In order to quantitatively assess the 
quality of these techniques, the SNR and CNR values of similar tissues were 
compared. The pre-analysis discussion concentrating on the spatial resolution 
and artifacts, supports that synthetic images have an advantage over DWI due to 
higher resolution and absence of artifacts. The SNR and CNR values were 
calculated for each patient and image type for the comparison, initially assuming 
that the synthetic images would have a higher mean SNR and CNR. In most 
cases the differences between scan types was found to not be statistically 
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significant. In conclusion, this analysis could not support the initial theory that 
the synthetic images had a  higher SNR or CNR. The research shows that they 
are more likely to be comparable. An investigation of the diagnostic power of the 
synthetic in comparison to standard DWI would give clinical relevance to these 
results. 
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INTRODUCTION 
 
Prostate cancer is the second leading cancer in men in the United States. It 
is predicted that 1 in 9 men will be diagnosed in his lifetime. The American 
Cancer Society predicts that in 2018 roughly 164,690 new cases will be diagnosed 
and that there will be more than 29,000 deaths due to the disease. Prostate cancer 
is the second leading cause of cancer death in American men, with lung cancer 
leading (Alteri et al., Key Statistics of Prostate Cancer, 2018). 
Diagnosis of prostate cancer involves biopsies and antigen testing, but 
Magnetic Resonance Imaging (MRI) has its value in monitoring the prognosis of 
the disease. Early stage cancers are less likely to be imaged as they are likely be 
contained to a small volume and less likely to have metastasized to other parts of 
the body. In the case of total prostatectomy, which is more common in early 
stage otherwise healthy adults, imaging is valuable for pre-surgical planning 
(Alteri, et al., Tests for Prostate Cancer, 2018). Mature and aggressive cancers call 
for high quality imaging to accurately locate and mark boundaries. MRI having a 
high-resolution and good contrast in soft tissue is invaluable for prostate cancer 
detection. 
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Diffusion weighted imaging (DWI) is a well understood MR methodology 
that uses pulsed gradient fields to encode the rate of movement of water bound 
hydrogen nuclei, it is particularly useful in the tracking of white matter within 
the brain. DWI on its own has reasonable diagnostic power but is known to be 
more effective when paired with T2 imaging (Tanimoto, et al., 2007). The 
European Society of Urogenital Radiology (ESUR) included DWI as a valuable 
tool for the characterization and the adding of specificity to T2 weighted images 
(Barentsz, et al., 2012). The utilization of both modalities in cancer definition 
showed a significantly higher chance of detection. 
Quantitative Magnetic Resonance Imaging (QMRI) is another form of MR 
imaging that computes the tissue characteristics that common MR weighting 
relies on (T1, T2, Diffusion) to then recreate the imaged patient in a new image 
that is termed a ‘Synthetic’ image. QMRI was originally thought to provide 
diagnostic data that is specific to diseased tissue, potentially opening the door for 
calculations to do the diagnostic work. Though it is true that pathologies have 
unique characteristics it is thought that the estimation of these values is not yet 
specific enough to diagnose diseased tissue. The application of QMRI in this 
study was for the production of synthetic diffusion images (sDWI) after the 
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patient had completed the original scan and then comparing its quality to a non-
quantified DWI of the same patient. 
DWI on its own has its uses in clinical monitoring of prostate cancer. 
Synthetic imaging is becoming more readily implemented in the clinical and 
setting. This study will compare the image quality of standard DWI to the 
synthetic by their signal-to-noise (SNR), contrast-to-noise (CNR), spatial 
resolution (SR), and artifacts. It is expected that the synthetic images will have 
better contrast as there is more signal processing involved that will ideally refine 
the image and reduce the contribution of noise to the image. The values of the 
DW images are compared to the synthetic images by these metrics, though the 
most important and clinically relevant metric is the diagnostic power, it is not 
included in the scope of this study. As a first step in assessing the quality 
between these image types this research asks and answers the question whether 
the objective image quantities of DWI and its synthetic imaging equivalent are 
the same or different. If one is greater than the other then the clinical protocol can 
be further informed on how to more quickly assess the prognosis of a patient.  
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BACKGROUND 
Prostate Anatomy and Physiology 
The prostate gland rests on the anterior portion of the rectum at the distal 
end of the peritoneal cavity, surrounding the first boundary of the proximal 
urethra. The prostate’s border is a thick connective tissue capsule enveloping 20 
to 30 tubuloalveolar glands embedded in smooth muscle and connective tissue 
(Marieb & Hoehn, 2013). The prostate has three zones: transition, central and 
peripheral. The transition zone is perforated by the urethra and contains 
permeable epithelium, which serves as the route by which the secreting fluid 
accesses the urethra. The central zone surrounds the ejaculatory duct and 
contains 25% of the glandular tissue. The peripheral zone houses 70% of the 
glandular tissue and surrounds the distal portion of the embedded urethra 
(Muruve, 2017). 
The prostate contains smooth muscle, connective tissue and glandular 
tissue. The outer most fascia is a dense fibrous connective tissue; just beneath and 
in circular bands around the urethra are smooth muscle tissue that perpetuates 
the flow of secretions and urine. Aside from the two primary layers, dense 
bundles of muscle fibers are embedded around and between the glandular tissue 
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within the prostate, stimulating the tissue in the flow of the secreted fluid (Gray, 
H. 2010). 
Benign Prostatic Hyperplasia 
The most common pathology regarding the prostate deals with its 
enlargement. Prostate cancer and Benign Prostatic Hyperplasia (BPH), both show 
as uncontrolled growth within the prostate gland and can understandably be 
misidentified as the other. Nearly 90% of males above the age of 80 are expected 
to experience BPH, an enlarging of the prostate that can eventually lead to 
significant health risks including blockage of the urinary tract, kidney damage, 
bladder stones, and urinary tract infections (Simon, 2014). Though the name 
states that this is not directly harmful, like a metastasized tumor, there are still 
risks. BPH increases the complexity of prostate cancer diagnosis, as the benign 
hyperplasia can be misread as a potentially life-threatening cancer and vice 
versa. This is because BPH also creates dense and hyper-perfuse masses that are 
readable on a MR and understandably misdiagnosed. This study includes the 
identification and measurements of both cancer and BPH because of the 
importance in differentiating the two clinically. Accounting for the overlapping 
image features should add the robustness of the methods used here. 
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Figure 1. Annotations on a transverse TSE image depicting two yellow ROI in 
the lateral hemispheres of the central gland with BPH. 
Prostate Cancer 
Although prostate cancer is prevalent and potentially lethal, it will not kill 
most of those who are diagnosed. Only 1 in 41 of all men diagnosed will die from 
it. Prostate cancer is often slow moving and 96% of men live at least another 15 
years after diagnosis (Alteri, et al., Key Statistics of Prostate Cancer, 2018). Most 
diagnoses are made with a blood test looking for Prostate Specific Antigen (PSA) 
or with a digital rectal exam (DRE). These two tests, as well as the Gleason score, 
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inform the oncologist as to how likely the cancer will spread quickly and require 
imaging techniques. Higher Gleason score and PSA levels would indicate a 
higher chance that the cancer will spread quickly (Alteri, et al., Key Statistics of 
Prostate Cancer, 2018).  This is where MRI is most valuable, in the actual grading, 
locating and approximation in size of the diseased mass, giving a more 
meaningful diagnosis. 
 Prostate-specific antigen (PSA) tests have been used since 1986 as a 
supplemental test to monitor the development of cancer in those that had already 
been diagnosed. The exam measures the concentration of the protein in the blood 
that is present in both healthy and malignant cells of the prostate; malignant 
cancers are correlated with producing an excess of this antigen and are thus used 
as a means of marking the progression of the cancer. However, elevated PSA 
levels are not the only means of diagnosis as both prostatitis and benign prostatic 
hyperplasia (BPH) are known to increase levels of PSA. DREs are often 
implemented along side PSA though it too has its own shortcomings as it only 
effectively monitors the posterior wall of the gland. MRI is not the first 
diagnostic tool used for prostate cancer; PSA and biopsy are considered better 
tools for detecting prostatic malignancies (Alteri, et al., Understanding Your 
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Pathology Report: Prostate Cancer., 2017). However, MRI is essential for grading 
cancers, the ability to determine the size, shape and location of tumors is 
necessary and best done with MR as CT and ultrasound cannot produce the 
same level of soft tissue contrast. 
 Recent studies have begun to show that PSA is potentially a dangerous 
tool when the only test for diagnosis of prostate cancer. The higher false positive 
rate is likely skewing statistics and misinforming doctors on the state of their 
patient. Fenton Et al. notes in their review in a study lasting over 10 years that 
there was an over diagnosis rate from 20% to 50%. This false positive rate can be 
dangerous as it complicates test results and wastes patient and physician’s time 
with lengthen visits as well as result in biopsy complications (Fenton, et al., 
2018). 
A biopsy of the prostate and a DRE will lead a physician to decide 
whether the enlargement is caused by BPH or a tumor. The test will score the 
cancer on the Gleason scale based on how similar the cells from the tumor look 
like normal prostate tissue. The higher the grade (Max: 10) the more abnormal or 
cancerous the cell samples are and the more likely they will replicate and spread 
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quickly (Alteri, et al., Understanding Your Pathology Report: Prostate Cancer., 
2017). 
Diffusion Weighted Imaging Magnetic Resonance Imaging 
 DW imaging is an MR technique that focuses on measuring the random 
movement of particles within a medium. This can be affected by the presence of 
a concentration gradient, or a pressure difference but the diffusion coefficient is 
known to be the combination of the effects of particle size, temperature, and 
viscosity. Glandular tissues and organs like the prostate can have different 
diffusion coefficient values that can return good contrast in comparison to tissues 
with lower diffusion values like fatty bone marrow. The MRI scanner uses a 
pulsed gradient field in a single direction on a timed interval; this encodes the 
space in one direction and allows for the tracking of the flow of water-bound-
hydrogen (Bihan & Johansen-Berg, 2011). The single exponent expression 
involves a constant b that represents the strength and timing of the gradient used 
in the pulse sequence and utilized in an exponential decay form: 
𝑆 = 𝑆0e
−𝑏∗𝐷 
(1) 
Where S is the measured signal after the diffusion gradients are applied, S0 
is the baseline MR signal; b is a scan specific gradient parameter that reflects the 
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duration and strength of the diffusion gradient, and D being the diffusion 
coefficient. 
Many imaging studies incorporate multiple b values for the purposes of 
producing contrast at different levels of diffusion to increase the chances of 
identification of specific pathology, often one high, one medium, and one low b 
value is utilized. The appropriate b value for assessing prostate cancer is heavily 
debated in the literature; this study uses a b value of 200 and makes no claim that 
this is the standard for prostate imaging but found it adequate in qualitative 
examination. 
 Diffusion MR uses an Echo Planar Imaging (EPI) pulse sequence for the 
reasonable purpose of acquiring slices quickly, producing an entire slice within 
100 milliseconds which is ideal for reducing motion artifacts. In this study the 
specific type of EPI was a Spin-echo EPI (SE-EPI) which rapidly flips the 
frequency encoding gradient as the transverse magnetization decays to get 
multiple readouts over a short period of time (Higgins, 2018). With the use of the 
pulsed gradient field the SE-EPI can produce fast changes in the position of 
water molecules and produce accurate diffusion images. 
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Quantitative Magnetic Resonance 
Standard Magnetic Resonance (MR) involves the interpretation of a 
qualitative image, interpreting the map of intensities and contrast to locate 
pathology and anatomical variances. QMRI utilizes the same physical properties 
and instrumentation as typical MR but instead indexes biophysical parameters 
such as proton density (PD), longitudinal magnetizationrelaxation (T1), and 
transverse magnetization relaxation (T2-, T2*) relaxation, quantified 
magnetization transfer, and diffusion rate (Shah B. et al., 2011). qMRI can 
accomplish this in two steps. First, qMRI pulse sequences are used to generate 
the magnetization vectors. By changing a single factor in the pulse sequence 
while pulsing the same slice a second time allows for the plotting of the signal 
intensity as the chosen factor changes. The relationship is known to be linear and 
only requires two different settings to quantize the target variable (e.g. T1, T2, 
PD, Diffusion) The independent factor can be the echo time, repetition time, and 
even flip angle. The second step takes these two returned signal maps and 
approximates the desired quantifiable characteristics using an algorithm based 
on the known signal-parameter relationship. 
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 The qMRI pulse sequence used in this work is the Tri-Turbo Spin Echo 
(Tri-TSE), it is the concatenation of a Dual Echo TSE (DE-TSE) to a Single Echo 
FSE (SE-TSE). This sequence produces a high quality quantitative image in a 
short scan time. QMRI has two primary advantages over standard MRI. First, 
standard MRI is heavily dependent on the operator selecting the appropriate 
settings; factors such as echo time, repetition time and the choice of pulse 
sequencing will change the resolution, signal-to-noise, contrast-to-noise and 
overall quality of the generated image. Secondly, QMRI has the benefit of 
potentially being faster due to the reduced number of sequences necessary. 
Standard MRI may have multiple sequences and therefore lengthens the scan 
time as opposed to quantitative, which can gather the precise tissue values with a 
single QMRI pulse sequence (Simon, 2014). 
 In addition to the pulse sequence enabling the scanner to produce high 
quality quantitative maps of the patient, the sequence itself is simply more robust 
than the echoplanar imaging (EPI) used in DWI. Tri-TSE is invulnerable to the 
distortions that are found in the diffusion EPI, producing more consistent and 
reliable images for diagnosis. The synthetic images could in fact be standardized 
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because of the reliability of the output and relative immunity to common 
artifacts. 
 Quantitative MRI is advantageous compared to DWI imaging creation 
and that is the ability to create images with multiple ‘b’ values. This is 
advantageous for multiple arbitrary ‘b’; first, the patient and scanner now save a 
significant amount of time. The protocol required to have 6 difference ‘b’ value 
DW images taken would significantly increase scan time and the probability of 
having motion artifacts. Additionally, the range of ‘b’ values used for DWI is 
limited by the hardware available, while a Tri-TSE pulse can scan once and then 
reproduce the wide range of ‘b’ values requested without any limitations. 
Finally, in regards to the estimation of SNR, synthetic images can have increased 
‘b’ values without effecting the noise of the image. The use of b=200 images in the 
comparison with the synthetic images is stronger because of the low noise that is 
inherent with the low ‘b’ value. 
Image Quality 
There are four main measures of image quality, and they are: SNR, CNR, spatial 
resolution, and artifacts. These are either quantifiable or independently assessed 
on a case by case basis. Though these are important the most important quality is 
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the ability to provide relevant data to a diagnosing agent in order that they 
improve the quality of life of an afflicted patient. This measure is not included in 
this research but is considered the next step in the comparison of synthetic and 
standard diffusion MRI. SNR is the ratio or the mean signal within a targeted 
area or region of interest (ROI) and the standard deviation of the noise of that 
same image. This value can estimate how much more visible is the targeted 
structure than the background noise that is known to perpetually exist. CNR is a 
similar quantity but is the comparison of signals of adjacent tissues that a reader 
may need to distinguish between such as cancerous and healthy tissues. SNR 
and CNR are completely dependent on the application of the scan and the one 
being scanned, variation of similar pathology is expected to vary between 
patients. The details on which scan type has better SNR and CNR are the bulk of 
this research. 
The type of artifacts that occur are dependent on the type of pulse 
sequence that is used. Tri-TSE has the advantage again by not seeming to 
produce any artifacts. DWI images on the other hand has a well-known artifact 
of distortion. This misregistration can occur from patient motion but it also 
known to occur spontaneously due to Eddy currents within the body. Eddy 
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currents can distort the image and contribute to diffusion sensitization that are 
not included in the calculation of the b-value (Pierpaoli, 2011). This is one reason 
why a synthetic image can be an advantage in the clinic. The susceptibility of the 
diffusion EPI can generate dangerously misrepresentative images that can skew 
intensity values. This study will point out data that is believed to be a result from 
this artifact and produces the data that further highlights the severity of this 
misrepresentation. This work is motivated in part by this need for a more 
consistent imaging method for diffusion in the prostate. 
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METHODS 
 28 men suspected of having prostate cancer, or diagnosed with cancer, 
were scheduled prostatic MRI scans at Boston Medical Center. These patients 
received both a series of diffusion-weighted scan as well as a quantitative Tri-
TSE pulse sequence. The images were then annotated by an experienced 
radiologist, marking ROIs in either the central or peripheral zones as either 
healthy, BPH, or cancerous. Subjects were further excluded from the analysis for 
having poor image quality, resulting in a final population study of 21 patients. 
The original ROIs ranged in size to appropriately capture the tissue but were 
often 4 millimeters in diameter. ROIs smaller than 4 millimeters were noted as 
being smaller for the purpose of catching any potential outliers. 
All MR images were obtained on a 1.5 T Phillips MRI while utilizing an 
endorectal coil. The sequences included the SE 2D EPI and Tri-TSE. The SE-EPI 
sequence had a TR of 3244 milliseconds and a TE of 61.63 milliseconds and a 
echo train length of 99. The slice depth was 3 millimeters. In the SE portion of the 
Tri-TSE sequence the repetition time of 5000, an echo time of 5.6 and train length 
of 4. The DE-TSE sequence had a TR of 2384, an echo time of 13.8, and a train 
length of 8. 
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To maintain the scope of this paper, the mathematical transition from the 
quantitative image acquisition to the synthetic image is not included. A simple 
step-by-step process should be adequate for understanding the origins of the 
sDWI image. The process that calculated the synthetic diffusion image was 
written in Mathcad that ran the following process. The process first began with 
the creation of a T1 Map based on the directly acquired images. 
 
Figure 2. T1 map of transverse prostate, first step in qMRI process for the 
Diffusion image. 
Next, the Mathcad program created a T2 map and then finally a PD map. 
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Figure 3. T2 map of transverse prostate, second step in qMRI process. 
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Figure 4. Proton Density map, third step in qMRI image creation. 
All three of these parameters are necessary for the mathematical process 
that produces the diffusion correlation time. The resulting diffusion map is a 
synthetic representation of what is done with an EPI pulse sequence. 
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Figure 5. Synthetic diffusion image, created by the calculation that incorporates 
the T1, T2, and PD images from the same Tri-TSE sequence. 
Image Annotation and ROI management 
 The ROIs included in the study were produced by an expert reader with 
18 years of experience and only included patients with clear pathology. Using 
Osirix the radiologist made annotations on T2 weighted TSE images, marking 
three different tissue types: healthy tissue, cancerous or BPH (within the central 
gland). The regions were color coded and made with the oval ROI drawing tool 
in Osirix. The healthy and cancerous tissues were noted as being located in either 
the peripheral or the central zones of the prostate. 
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Figure 6. Annotated Transverse prostate with a TSE pulse sequence. Green ROI 
on the left lateral peripheral zone indicates healthy tissue in the peripheral zone. 
The Red ROI in the more medial peripheral zone marks the cancer also found in 
the peripheral zone. 
 
 In Osirix the ROIs on the TSE images were then copied to both the DW 
b200 slices and the Dual Echo TSE (DE) images. The ROI name, slice number, 
and X-Y coordinates (pixels) were recorded for every ROI on both image types. 
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Noise Estimation 
 Noise was calculated in accordance to the method set by Metens, et al. 
where they drew an ROI on the pelvic bone where there is little to no signal, any 
existing signal represents the noise in the image (Metens, et al., 2012). The first 
noise ROI is drawn on the TSE image where the bone is most clearly seen then 
the ROI is copied to the DW and DE image on the corresponding slice where the 
location is noted in pixels. In FIJI the corresponding image is opened and using 
the selections tool, an oval 3.0 millimeter diameter ROI is drawn centered on the 
location noted in Osirix. The standard deviation is measured within the ROI and 
taken as the standard deviation of the noise for that image type and only for that 
patient.  
SNR and CNR Calculation 
 Using the same selection tools used for calculating the noise of the image 
the ROIs first annotated by the radiologist are transferred to the synthetic and 
DW images in FIJI. Selecting the coordinates in pixels and a setting the ROI 
diameter to be 3.0 millimeters. Using the ‘Measure’ tool in FIJI, the mean signal 
was calculated within each ROI. 
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 Using (eq.2) the SNR of the Central-Healthy (C-H), Peripheral-Healthy (P-
H), Central-BPH (CB), Central Lesion (CL), and Peripheral Lesion (PL) for each 
patient, if available, were recorded. Contrast was calculated for the comparison 
between every tissue type, making 4 key contrast variables: Central Healthy-
Lesion (CH-L), Central Lesion-BPH (CL-B), Central Healthy-BPH (CH-B), and 
Peripheral Healthy-Lesion (PH-L).  
𝑆𝑁𝑅 =
𝑆𝑡𝑖𝑠𝑠𝑢𝑒
𝜎𝑛𝑜𝑖𝑠𝑒
 
(2) 
Where 𝑆 is the mean signal of the tissue bound within the ROI and 𝜎𝑛𝑜𝑖𝑠𝑒 
is the standard deviation of the signal found within the pelvis that is determined 
to have low enough signal in diffusion images to correlate to the noise of the 
image. The SNR value was calculated by dividing the mean ROI signal by the 
standard deviation of the noise (Metens, Miranda, Absil, & Matos, 2012). 
The SNR is proportional to the voxel size and thus the need for voxel size 
saling the measurements. Since the synthetic images have a smaller voxel volume 
by a factor of 4.9 the SNR will be 4.9 times smaller even the images were identical 
(George, et al., n.d.). Therefore, the SNR values of the synthetic images are 
multiplied by a factor of 4.9 to have a proper comparison. 
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𝐶𝑁𝑅 =
𝑆𝐴 − 𝑆𝐵
𝜎𝑛𝑜𝑖𝑠𝑒
 
(3) 
Where 𝑆𝐴 is the mean tissue signal that is arbitrarily designated tissue A in 
comparison with tissue B where its mean signal is represented by 𝑆𝐵. The 
calculation of contrast was the difference between the mean ROI signals divided 
by the slice’s noise standard deviation (Metens, et al., 2012). Because most 
patients had multiple lesions or examples of healthy tissues, the average signal 
was calculated for each tissue type per patient, these average values were used to 
calculate the two CNR groups. The CNR value per patient can be understood as 
an average value rather than a ROI specific value. 
 Only two contrast parameters were achievable with the data given: 
between the healthy and cancerous lesions in the peripheral zone (PH-L) and 
between BPH and cancerous lesions in the central zone (CB-L). 
 
Statistical Analysis 
 The descriptive cross-sectional study took the 21 subjects to measure the 
SNR and CNR values of three different tissue types and compared them across 
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scan type. Each patient being exposed to an assembly of the varying tissue types 
(healthy, cancerous, and BPH) as well as being scanned with both the synthetic 
and standard diffusion sequences. The measured outcomes being the SNR of the 
available tissue types according to their location and the average CNR values. 
The statistical analysis was done on IBM’s SPSS 23TM, the alpha was set to be 0.05. 
The SNR within each scan group of every tissue type were tested for normality 
with the Shapiro-Wilk test. If normality was supported the means difference 
between scan was tested by a one-way ANOVA. If the normality was not 
supported then a Mann-Whitney comparison was used. The averaged CNR 
values are also tested for normality across all patients while also grouped by scan 
type. If normality was supported then a One-way ANOVA compared the means 
between the scan types and a Mann-Whitney if normality was not supported. 
The homogeneity of variance was tested in conjunction with the One-Way 
ANOVAs with the Levene’s test. The Levene’s null assumes the variances 
between the groups are equivalent. 
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RESULTS 
 The resulting images produced are both of good quality and have a good 
anatomical representation of the transverse prostate. 
 
Figure 7. (Left) b200 Transverse slice of the prostate. (Right) Synthetically 
acquired diffusion correlation time maps. 
 Though the DWI image appears to have less detail than the synthetic 
images, the targeted tissues in all images are within the visible region of the 
prostate. 
 The 21 patients had tumors in the peripheral zone, central zone, or both. 
The SNR means were tested with the 1-Way ANOVA which has a null that 
assumes the means are of the same population. All but the central lesion ROIs 
did not have normally distributed populations. The difference in mean SNR of 
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the healthy peripheral and central BPH between the scan types were shown to be 
statistically significant (p<0.001, p<0.05). In these cases the healthy peripheral 
tissue and the central BPH both had the DWI scan have a higher SNR value. 
Table 1. Mean SNR value of tissues according to image type with meant 
comparison test and p value 
SNR  Tissue N Means Std. Dev. Test p 
CB 
DWI b200 39 107.9 121.8 
1-Way ANOVA (F) <0.05 Synthetic 39 61.2 32.4 
CL 
DWI b200 7 46.6 26.4 
1-Way ANOVA (F) 0.485 Synthetic 7 54.9 15.5 
PH 
DWI b200 49 170 155.9 
1-Way ANOVA (F) <0.001 Synthetic 48 69.6 39.7 
PL 
DWI b200 38 789.8 3827.2 
1-Way ANOVA (F) 0.197 Synthetic 40 56.8 35.3 
 
The comparison in means in the peripheral healthy tissue shows the 
magnitude of the outliers identified in the Stem-Leaf, but despite the variability it 
adds, mean difference was still found to be statistically significant (p<0.001). 
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Figure 8. Boxplot of SNR in the Peripheral Healthy Tissue. ‘SNRprop’ refers to 
the SNR values being proportional to the voxel size. 
 Table 2. Variance and 95% Confidence Intervals (CI) of the tissue SNR 
 
 The Levenne’s difference in variance test shows that most of the samples 
had a difference in variance between the scan types. The only exception was that 
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of the central lesions, which will be discussed later in its implications has a 
significantly lower sample size. 
Contrast values could only be drawn between the peripheral healthy and 
cancerous tissues (N=20) as well as between the central BPH and cancerous 
tissues (N=4). Though the test supported that the population was normally 
distributed for the central contrast, due to the low sample size the results are 
suspect. The ANOVA showed that neither the contrast within the peripheral 
gland nor the central gland had a statistically significant difference in means 
between the scan types (p=0.278,p=0.5). 
Table 3. Contrast-to-Noise means comparison 
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Figure 9. Boxplot depicting CNR of BPH against Cancerous lesions in the Central 
gland as they differ between Image Type 
The boxplot (fig. 2) shows the degree of variability between the DWI and 
synthetic contrast. Though the images are found to have the same means, the 
variability is clearly different. Similar box plots depicting the SNR comparisons 
for the peripheral lesions, central BPH, and central lesions are in the Appendix. 
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Table 4. Variance and 95% CI of tissue CNR 
 
The Levenne’s test supported that the variance in all cases were different 
between the scan. However, it should be noted that though the CB-L shows a 
suitable rejection the power of the tests is still suspect and all results were 
scrutinized. 
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Figure 10. Boxplot of CNR between peripheral Healthy and Cancerous tissue. 
For the purpose making the box plot easier to read, values over 60 were excluded 
and considered outliers, but were not removed from the analysis. 
DISCUSSION 
The pre-analysis first discussed the independent image quality variables, 
spatial resolution and artifact. The first two parameters indicate that synthetic 
images have the advantage in this case with a higher spatial resolution and the 
ability to provide better contrast. In terms of artifacts, it is considered to not be an 
issue for synthetic processing with the Tri-TSE pulse sequence while the 
diffusion EPI images has several artifacts the most significant being geometric 
distortion. The results provided data that contradicted the assumption that the 
synthetic images would have both higher SNR and CNR values, despite the 
advantage they have regarding the first two parameters. 
Outliers were kept within the data as there was no other reason to remove 
them besides their variance. The outliers were identified in the Stem-And-Leaf 
analysis when testing for normality. 
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Figure 11. SNR of Peripheral Healthy tissue including outliers. 
The data was found to have a few key patients that repeatedly had values 
identified as outliers. These patients were included in all analysis because of the 
lack of other criteria for exclusion. The images were measured a second time for 
verification and found the variation to be consistent. It his hypothesized that this 
is because the diffusion images are susceptible to distortion artifacts and these 
variation are the result of potentially sampling outside of the prostate. This 
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seems to be the most likely case, that the extremity of these outliers is based on 
the distortion artifact; if it is, the data shows that there was a distortion artifact 
occurrence rate of 14% with 3 out of 21 cases being visibly unique in figure 11. 
This further illustrates the need for synthetic images to be utilized as a possible 
alternative to standard DWI. 
In regards to the measured values from this study (SNR and CNR) the 
following conclusions were made. The SNR of the DWI images that were 
significantly different were always higher than the synthetic images. Only in the 
cases cancerous lesions in both zones were the means not found to be 
significantly different. For the analysis on the SNR within each the image type 
though, all but the peripheral lesions proved to be different. The findings 
showed that the means were statistically different and in fact resulted in a higher 
mean in the DWI images. This appears to be because of the noise difference 
between the synthetic and diffusion images. 
Comparing the means of the standard deviation of the noise for each of 
the image types shows that the difference is statistically significant when testing 
with an ANOVA (p<0.001). The diffusion images had an average noise standard 
deviation of 2.36 while the synthetic images had a mean of 74.8. It is still unclear 
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as to why this appears in synthetic images and may be resolved by the continual 
work on qMRI. 
In the case of CNR there was no difference between the scans. As 
mentioned before the CNR values were calculated between the average healthy, 
BPH, and cancerous tissues; thus producing one value per parameter per patient. 
The small sample size as well for the contrast specifically within the central 
gland makes it difficult to make the comparison and likely has a problem with its 
statistical power. 
The Levenne’s test compared the variances in the SNR and CNR values 
between scan types supported that for nearly all parameters the variances were 
different, the only exception being the SNR of the central lesions. This unique 
homogeneity of variance is possibly because of the low statistical power of the 
test due to the small sample size of central lesions. 
The most significant limitations of this study are the sample sizes and the 
matchings available for contrast calculations. Contrast was only analyzed for 
tissues found in the same zones, thus BPH was never contrasted to healthy 
peripheral tissue, limiting the analysis to only 4 samples. This was done as it was 
considered the more relevant comparison thought healthy peripheral tissue can 
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appear close to BPH found in the central gland. This decision limited the CNR 
values to only two comparisons which may give an incomplete picture of all 
desirable contrasts. 
A second limitation is the method used in estimation of noise within the 
images. The method was replicated from the study that Metens et al. utilized in 
similar research and considered acceptable during the testing phase. Drawing an 
ROI on the pelvic bone to measure the noise does appear reasonable. However, 
the notably larger variation in noise in the synthetic images versus the DWI drew 
some skepticism in the method and a desire to investigate it further. A follow up 
study would benefit from using other and multiple methods for assessing the 
noise variation. 
The above results provided some unexpected results. It was initially 
thought that synthetic images appearing to be higher quality would result in 
higher SNR and CNR values, the results show that there is either no difference or 
that DWI has a higher SNR and CNR. It seems that it is more likely that they are 
at least comparable when balancing all of the metrics of image quality. This is 
based on the analysis used and the discussion after reviewing the results 
concluded that a follow up study would benefit from taking some specific 
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actions to produce a more conclusive result. This study solely focused on the 
four objective image quality parameters; as mentioned in the beginning it does 
not address the qualitative factor, the diagnostic power. This study is an 
objective assessment of the 4 most relevant image quality parameters and stands 
as a preliminary to a clinical assessment of these scan types. An analysis that 
addresses how efficient an image type is at informing a radiologist or diagnosing 
agent is the one that drives innovation and image refinement. If this study were 
to continue, perhaps a more informative data set would include multiple 
radiologists that would then diagnose and locate the cancers and BPH within 
each patient and comparing the accuracy across scan type. 
In conclusion, the pre-analysis highlights the advantages that synthetic 
images could have over the standard diffusion, being superior in both spatial 
resolution and less vulnerable to motion and susceptibility artifacts. The EPI 
DWI pulse sequence is less robust relative to Tri-TSE used in qMRI, which drove 
the research to look to synthetic diffusion images as a substitute for standard 
DWI. The SNR and CNR values in the central and peripheral zones did not 
conclusively point to one scan type being better than the other. In regards to SNR 
and CNR the analysis points to the scan types as being more often the same than 
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different; in fact, only two cases had statistically different means out of 7, and 
though they both favored standard DWI. Because of this inconsistency the 
conclusion cannot convincingly support DWI as being more advantageous than 
synthetic. This objective study hopefully sets the stage for an analysis that 
focuses on the diagnostic power of these scans, providing clinical relevance to 
the research described here. 
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APPENDIX A 
 
 
 
Figure 12. SNR of cancer in the peripheral zone and how they compare between 
image types. For the purpose of easier viewing of the box plot, SNR values over 
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400 were excluded and counted as outliers but were not removed from the 
analysis. 
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APPENDIX B 
 
Figure 13. SNR of BPH in the central gland, comparing the DWI and synthetic 
scans 
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APPENDIX C 
 
Figure 14.SNR of tumors in the central gland comparing image types. 
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